Acute effects of ingestion of black and green tea on lipoprotein oxidation

American Journal of Clinical Nutrition

Volumn 71, Issue 5, 2000, Pages 1103-1107

  Hodgson, Jonathan M ^a   Puddey, Ian B ^a   Croft, Kevin D ^a   Burke, Valerie ^a   Mori, Trevor A ^a   Caccetta, Rima Abu Amsha ^a   Beilin, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antioxidant; Australia; Black tea; Caffeine; Flavonoid; Green tea; Lipoprotein; Polyphenolic compounds

Indexed keywords

GALLIC ACID METHYL ESTER; LOW DENSITY LIPOPROTEIN; POLYPHENOL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; SERUM; TEA; URINE;

CAMELLIA SINENSIS;

EID: 0034110197     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.5.1103     Document Type: Article

References (27)

1. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease. Lancet 1993;342:1007-11.
2. Jick H, Miettinen OS, Neff RK, Shapiro S, Heinonen OP, Slone D. Coffee and myocardial infarction. N Engl J Med 1973;289:63-7.
3. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 1996;156:637-42.
4. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-6.
5. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996;312:478-81.
6. Frankel EN, Kanner J, German JB, Parks E. Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
7. Witzturn JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
8. Hodgson JM, Mori TA, Puddey IB, Croft KD, Beilin LJ. In vitro antioxidant activity of black and green tea: effects on lipoprotein oxidation in human serum. J Sci Food Agric 1999;79:561-6.
9. McAnlis GT, McEneny J, Pearce J, Young IS. Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 1998;52:202-6.
10. Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 1996;50:28-32.
11. van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 1997;66:1125-32.
12. Ishikawa T, Suzukawa M, Ito T, et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997;66:261-6.
13. Princen HM, van Duyvenvoorde W. Buytenhek R, et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vase Biol 1998;18:833-41.
14. van het Hof KH, Wiseman SA, Yang CS, Tijburg LBM. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med 1999;220:203-9.
15. Carbonneau MA, Leger CL, Monnier L. et al. Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu(2+)-oxidizability: possible explanation by phenolic location. Eur J Clin Nutr 1997;51:682-90.
16. Yamakoshi J, Kataoka S, Koga T, Ariga T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999;142: 139-49.
17. Shahrzad S, Bitsch I. Determination of gallic acid and its metabolites in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998;705:87-95.
18. Abu-Amsha Caccetta R, Croft KD, Beilin LJ, Puddey IB. Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr 2000;71:67-74.
19. Regnstrom J, Strom K, Moldeus P, Nilsson J. Analysis of lipoprotein diene formation in human serum exposed to copper. Free Radic Res Commun 1993;19:267-78.
20. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beilin LJ. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J Nutr Biochem 1996;7:664-9.
21. Proudfoot JM, Puddey IB, Beilin LJ, Stocker R, Croft KD. Unexpected dose response of copper concentration on lipoprotein oxidation in serum: discovery of a unique peroxidase-like activity of urate/albumin in the presence of high copper concentrations. Free Radic Biol Med 1997;23 699-705.
22. Valkonen M, Kuusi T. Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J Lipid Res 1997;38:823-33.
23. Helrick K. Official methods of analysis. 15th ed. Arlington, VA: Association of Official Analytical Chemists, 1990:703.
24. Luz Cardona M, Fernandez I, Begona Garcia M, Pedro JR. Synthesis of natural polyhydroxystilbenes. Tetrahedron 1986;42: 2725-30.
25. Harbowy ME, Ballentine DA. Tea chemistry. CRC Crit Rev Plant Sci 1997;16:415-80.
26. Frei B. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. CRC Crit Rev Food Sci Nutr 1995;35:83-98.
27. van het Hof KH, Kivitis GAA, Westrate JA, Tijburg LBM. Bioavail-ability of catechins from tea - the effect of milk. Eur J Clin Nutr 1998;52:356-9.